Atlas Trials

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

Clinical trial NCT01364974 · COMPLETED

Trial details

NCT number
NCT01364974
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy SubjectsPharmacokinetics of ASP015KPharmacodynamics
Start date
2009-01-01
Primary completion
2009-05-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.